Peter E. Andreotti

1.9k total citations
37 papers, 1.6k citations indexed

About

Peter E. Andreotti is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Peter E. Andreotti has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Biomedical Engineering and 8 papers in Oncology. Recurrent topics in Peter E. Andreotti's work include bioluminescence and chemiluminescence research (9 papers), Biosensors and Analytical Detection (6 papers) and Immunotherapy and Immune Responses (3 papers). Peter E. Andreotti is often cited by papers focused on bioluminescence and chemiluminescence research (9 papers), Biosensors and Analytical Detection (6 papers) and Immunotherapy and Immune Responses (3 papers). Peter E. Andreotti collaborates with scholars based in United States, United Kingdom and Germany. Peter E. Andreotti's co-authors include Christian M. Kurbacher, Ian A. Cree, Peter Cresswell, Howard W. Bruckner, John Apgar, Dieter Krebs, Uwe Wagner, I A Cree, Michael Untch and D N Howell and has published in prestigious journals such as The Journal of Immunology, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

Peter E. Andreotti

37 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter E. Andreotti United States 21 602 479 255 246 171 37 1.6k
Renaud Léonard United Kingdom 30 1.3k 2.2× 664 1.4× 468 1.8× 82 0.3× 262 1.5× 100 3.1k
Meghdad Abdollahpour‐Alitappeh Iran 22 593 1.0× 550 1.1× 311 1.2× 123 0.5× 122 0.7× 81 1.6k
Tai‐Tung Yip United States 24 1.5k 2.5× 304 0.6× 141 0.6× 136 0.6× 203 1.2× 43 2.6k
Ross Davey Australia 21 802 1.3× 730 1.5× 91 0.4× 46 0.2× 117 0.7× 43 1.7k
Vítor M. Faça Brazil 29 2.1k 3.5× 449 0.9× 335 1.3× 411 1.7× 182 1.1× 92 3.2k
Arvinder Kapur United States 20 862 1.4× 333 0.7× 531 2.1× 82 0.3× 109 0.6× 39 1.6k
Jérôme Solassol France 29 1.6k 2.6× 751 1.6× 355 1.4× 149 0.6× 383 2.2× 118 2.8k
Valérie Gouyer France 28 1.2k 1.9× 632 1.3× 392 1.5× 42 0.2× 276 1.6× 52 2.1k
Gary S. David United States 16 772 1.3× 230 0.5× 227 0.9× 55 0.2× 167 1.0× 41 1.7k
DaRue A. Prieto United States 18 1.1k 1.9× 204 0.4× 192 0.8× 133 0.5× 117 0.7× 34 1.8k

Countries citing papers authored by Peter E. Andreotti

Since Specialization
Citations

This map shows the geographic impact of Peter E. Andreotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Andreotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Andreotti more than expected).

Fields of papers citing papers by Peter E. Andreotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E. Andreotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Andreotti. The network helps show where Peter E. Andreotti may publish in the future.

Co-authorship network of co-authors of Peter E. Andreotti

This figure shows the co-authorship network connecting the top 25 collaborators of Peter E. Andreotti. A scholar is included among the top collaborators of Peter E. Andreotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter E. Andreotti. Peter E. Andreotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glaysher, Sharon, Dennis Yiannakis, Francis G Gabriel, et al.. (2009). Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC). BMC Cancer. 9(1). 300–300. 33 indexed citations
2.
Gehring, Andrew, Peter L. Irwin, Sue Reed, et al.. (2004). Enzyme-linked immunomagnetic chemiluminescent detection of Escherichia coli O157:H7. Journal of Immunological Methods. 293(1-2). 97–106. 37 indexed citations
3.
Cáceres, Gisela, et al.. (2003). Determination of chemotherapeutic activity in vivo by luminescent imaging of luciferase-transfected human tumors. Anti-Cancer Drugs. 14(7). 569–574. 18 indexed citations
4.
Cáceres, Gisela, et al.. (2003). Imaging of luciferase and GFP‐transfected human tumours in nude mice. Luminescence. 18(4). 218–223. 31 indexed citations
5.
Andreotti, Peter E., et al.. (2003). Luminescence Applications for Chemotherapeutic Drug Development. Recent results in cancer research. 161. 3–12. 6 indexed citations
6.
Kurbacher, Christian M., et al.. (2002). Chemosensitivity of normal human trophoblasts evaluated by a newly developed ATP-based luminescence assay. Anti-Cancer Drugs. 13(7). 701–708. 3 indexed citations
7.
Andreotti, Peter E., et al.. (1999). Application of a new high sensitivity luminometer for industrial microbiology and molecular biology. Luminescence. 14(1). 19–22. 3 indexed citations
8.
Cree, Ian A., Michael H. Neale, Nyree Myatt, et al.. (1999). Heterogeneity of chemosensitivity of metastatic cutaneous melanoma. Anti-Cancer Drugs. 10(5). 437–444. 45 indexed citations
9.
Kurbacher, Christian M., Ian A. Cree, Howard W. Bruckner, et al.. (1998). Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer. Anti-Cancer Drugs. 9(1). 51–57. 105 indexed citations
10.
Cree, Ian A. & Peter E. Andreotti. (1997). Measurement of cytotoxicity by ATP-based luminescence assay in primary cell cultures and cell lines. Toxicology in Vitro. 11(5). 553–556. 76 indexed citations
11.
Cree, Ian A., Christian M. Kurbacher, Michael Untch, et al.. (1996). Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity. Anti-Cancer Drugs. 7(6). 630–635. 68 indexed citations
12.
Kurbacher, Christian M., et al.. (1996). Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Letters. 103(2). 183–189. 189 indexed citations
13.
Kurbacher, Christian M., Ian A. Cree, Howard W. Bruckner, et al.. (1996). Heterogeneity ofin vitro chemosensitivity in perioperative breast cancer cells to mitoxantroneversus doxorubicin evaluated by a microplate ATP bioluminescence assay. Breast Cancer Research and Treatment. 41(2). 161–170. 20 indexed citations
14.
Cree, Ian A., Mario Pazzagli, Enrico Mini, et al.. (1995). Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures. Anti-Cancer Drugs. 6(3). 398–404. 29 indexed citations
15.
16.
Sutherland, Lesley, et al.. (1994). The influence of storage on cytotoxic drug activity in an ATP-based chemosensitivity assay. Anti-Cancer Drugs. 5(2). 171–176. 18 indexed citations
17.
Andreotti, Peter E., et al.. (1994). TCA‐100 tumour chemosensitivity assay: Differences in sensitivity between cultured tumour cell lines and clinical studies. Journal of Bioluminescence and Chemiluminescence. 9(6). 373–378. 34 indexed citations
18.
Petty, Robert, et al.. (1994). Expression of the p53 Tumor Suppressor Gene Product Is a Determinant of Chemosensitivity. Biochemical and Biophysical Research Communications. 199(1). 264–270. 40 indexed citations
19.
Andreotti, Peter E., et al.. (1989). Microbioluminometry Assay: Determination of Erythromycin Activity in Plasma or Serum. Journal of Pharmaceutical Sciences. 78(12). 979–985. 1 indexed citations
20.
Perkins, Sherrie L., Peter E. Andreotti, Sudhir K. Sinha, Ming‐Chi Wu, & Adel A. Yunis. (1984). Human myeloid leukemic cell (HL-60) autostimulator: relationship to colony-stimulating factor.. PubMed. 44(11). 5169–75. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026